Hyderabad: Hyderabad-based MSN Laboratories (MSN Labs) launched Empagliflozin tablets (SGLT2i), a drug used for diabetes management, under the brand name ‘Empaone’. The medicine will cost Rs 15.90 and Rs 18.90 for each 10 mg and 25 mg tablet, respectively. India being the diabetic capital of the world with over 77 million people suffering from Type […]
The clinical trial, published in the Journal of the American College of Cardiology, showed that this medication can improve the heart's size, shape, and function, leading to better exercise capacity and quality of life
